Physician profile
Stephen D Owens
NPI 1104834423
$10,346.46
in general payments reported to CMS, 2019-2025
23 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,541 · 2020: $1,241 · 2021: $867 · 2022: $1,052 · 2023: $1,120 · 2024: $1,356 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,645.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $3,263.25 | 2019-2021 | |
| Abbvie INC. | $1,555.12 | 2022-2025 | |
| Allergan, INC. | $1,077.69 | 2019-2022 | |
| Alcon Vision LLC | $826.36 | 2022-2025 | Rocklatan, Hydrus Microstent, Rhopressa |
| Bausch & Lomb Americas INC. | $824.45 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $767.39 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $608.66 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Amo Phaco Needle |
| Sight Sciences, INC. | $449.86 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Sun Pharmaceutical Industries INC. | $179.01 | 2021-2024 | |
| Nova Eye, INC. | $102.67 | 2024 | |
| Eyevance Pharmaceuticals LLC | $102.05 | 2022 | |
| Oyster Point Pharma, INC. | $87.21 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $72.37 | 2019-2021 | |
| New World Medical,INC. | $65.59 | 2022-2024 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Akorn, INC. | $64.43 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $59.17 | 2024-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $50.91 | 2020-2023 | |
| Akorn Operating Company LLC | $47.61 | 2021 | |
| Ocular Therapeutix, INC. | $42.99 | 2019-2022 | |
| Iridex Corporation | $33.44 | 2022 | |
| Shire North American Group INC | $31.37 | 2019 | |
| Ivantis, INC | $20.20 | 2021 | |
| Medtronic Vascular, INC. | $14.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.